Trial Profile
Nebivolol in prevention of contrast induced nephropathy : A single center experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Coronary artery disease; Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 14 Oct 2016 New trial record